MYC and cancer: In parallel, subclone-specific mutated genes are highly enriched in cancer-related pathways, including MYC target, G2M checkpoints, and mitotic spindle, and immune-related pathways, such as interferon response, TNF-a signaling, and inflammatory response (Additional file 6: Table S6).